Estrogen replacement in postmenopausal women has been associated with a reduction in circulating NEFA during hyperinsulinemia (87), but the precise impact of HRT on adipose tissue insulin sensitivity has yet to be defined using gold-standard measurements of adipose tissue insulin resistance. The gene discussed is INS; the disease is hyperinsulinism.